Sweden
· Delayed Price · Currency is SEK Hansa Biopharma AB Statistics
Total Valuation
STO:HNSA has a market cap or net worth of SEK 1.70 billion. The enterprise value is 2.47 billion.
| Market Cap | 1.70B |
| Enterprise Value | 2.47B |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:HNSA has 67.81 million shares outstanding. The number of shares has increased by 26.66% in one year.
| Current Share Class | 67.81M |
| Shares Outstanding | 67.81M |
| Shares Change (YoY) | +26.66% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.29% |
| Owned by Institutions (%) | 12.89% |
| Float | 37.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.37 |
| PB Ratio | -2.73 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.95 |
| EV / Sales | 13.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.87 |
Financial Position
The company has a current ratio of 1.83
| Current Ratio | 1.83 |
| Quick Ratio | 1.82 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.60 |
| Interest Coverage | -5.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -46.04% |
| Return on Invested Capital (ROIC) | -73.10% |
| Return on Capital Employed (ROCE) | -126.92% |
| Revenue Per Employee | 1.32M |
| Profits Per Employee | -4.53M |
| Employee Count | 135 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 42.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.42% in the last 52 weeks. The beta is 1.65, so STO:HNSA's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | -21.42% |
| 50-Day Moving Average | 23.64 |
| 200-Day Moving Average | 33.29 |
| Relative Strength Index (RSI) | 51.26 |
| Average Volume (20 Days) | 223,444 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:HNSA had revenue of SEK 181.68 million and -625.74 million in losses. Loss per share was -9.39.
| Revenue | 181.68M |
| Gross Profit | 95.76M |
| Operating Income | -565.66M |
| Pretax Income | -622.43M |
| Net Income | -625.74M |
| EBITDA | -563.18M |
| EBIT | -565.66M |
| Loss Per Share | -9.39 |
Balance Sheet
The company has 250.20 million in cash and 1.02 billion in debt, giving a net cash position of -767.93 million or -11.32 per share.
| Cash & Cash Equivalents | 250.20M |
| Total Debt | 1.02B |
| Net Cash | -767.93M |
| Net Cash Per Share | -11.32 |
| Equity (Book Value) | -623.74M |
| Book Value Per Share | -9.20 |
| Working Capital | 215.91M |
Cash Flow
In the last 12 months, operating cash flow was -637.61 million and capital expenditures -628,000, giving a free cash flow of -638.24 million.
| Operating Cash Flow | -637.61M |
| Capital Expenditures | -628,000 |
| Free Cash Flow | -638.24M |
| FCF Per Share | -9.41 |
Margins
| Gross Margin | 52.71% |
| Operating Margin | -311.34% |
| Pretax Margin | -342.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:HNSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.66% |
| Shareholder Yield | -26.66% |
| Earnings Yield | -36.76% |
| FCF Yield | -37.50% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |